Physician profile
Matthew D Smith
NPI 1780817551
$4,090.05
in general payments reported to CMS, 2019-2025
19 companies · $720 in 2025
The $720 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $719 · 2020: $288 · 2021: $640 · 2022: $731 · 2023: $419 · 2024: $572 · 2025: $720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,712.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,075.72 | 2019-2022 | |
| Abbvie INC. | $857.93 | 2022-2025 | Vuity, Lumigan, Durysta |
| Glaukos Corporation | $456.17 | 2019-2025 | Idosetr |
| Alcon Vision LLC | $391.49 | 2019-2025 | Rocklatan, Tryptyr, Clareon |
| Johnson & Johnson Surgical Vision, INC. | $233.46 | 2019-2024 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Sun Pharmaceutical Industries INC. | $146.64 | 2019-2023 | Cequa |
| Dompe US, INC. | $145.68 | 2024 | Oxervate |
| Ivantis, INC | $144.99 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $117.45 | 2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $105.74 | 2019-2021 | |
| Rxsight INC | $104.86 | 2021 | |
| Ocular Therapeutix, INC. | $100.00 | 2022 | |
| Bausch & Lomb Americas INC. | $58.99 | 2022-2024 | Vyzulta, Miebo |
| Tarsus Pharmaceuticals, INC. | $37.12 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $35.86 | 2020-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.40 | 2019 | |
| Sight Sciences, INC. | $22.31 | 2024 | Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $17.39 | 2019 | |
| Quidel Corporation | $15.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.